Skip to main content
Have a personal or library account? Click to login
Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting Cover

Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting

Acta Pharmaceutica
Volume 61 (2011): Issue 2 (June 2011)
By: ,  ,  ,   and    
Open Access
|Jun 2011
References

References

  1. E. Baloglu and D. G. Kingston, The taxane diterpenoids,(1999) 1448-1472.
    Open DOISearch in Google Scholar
  2. S. B. Horwitz, Taxol (paclitaxel): mechanisms of action,(Suppl. 6) (1994) S3-S6.
    Search in Google Scholar
  3. A. K. Singla, A. Garg and D. Aggarwal, Paclitaxel and its formulations,(2002) 179-192; DOI: 10.1016/S0378-5173(01)00986-3.
    Open DOISearch in Google Scholar
  4. J. C. Olivier, Drug transport to brain with targeted nanoparticles,(2005) 108-119.
    Open DOISearch in Google Scholar
  5. N. R. Saunders, M. D. Habgood and K. M. Dziegielewska, Barrier mechanisms in the brain, I. Adult brain,(1999) 11-19.
    Open DOISearch in Google Scholar
  6. J. Kreuter, R. N. Alyautdin, D. A. Kharkevich and A. A. Ivanov, Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles),(1995) 171-174; DOI: 10.1016/0006-8993(95)00023-J.
    Open DOISearch in Google Scholar
  7. C. M. Lopes, J. M. S. Lobo, J. F. Pinto and P. C. Costa, Compressed matrix core tablet as a quick/slow dual component delivery system containing ibuprofen,(2007) E1-E8; DOI: 10.1208/pt0803076.
    Open DOISearch in Google Scholar
  8. A. B. Dhanikula and R. Panchagnula, Preparation and characterization of water-soluble prodrug, liposomes and micelles of paclitaxel,(2005) 75-91.
    Open DOISearch in Google Scholar
  9. J. J. Marty, R. C. Oppenheimer and P. Speiser, Nanoparticles - a new colloidal drug delivery system,(1978) 17-23.
    Search in Google Scholar
  10. W. Lin, M. C. Garnett, E. Schacht, S. Davis and L. Illum, Preparation and in vitro characterization of HSA-mPEG nanoparticles,(1999) 161-170; DOI: 10.1016/S0378-5173(99)00253-7.
    Open DOISearch in Google Scholar
  11. K. Michaelis, M. M. Hoffman, S. Dreis, E. Herbert, R. N. Alyautdin, M. Michaelis, J. Kreuter and K. Langer, Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain,(2006) 1246-1253.
    Open DOISearch in Google Scholar
  12. T. Govender, S. Stolnik, M. C. Garnett, L. Illum and S. S. Davis, PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug,(1999) 171-185; DOI: 10.1016/S0168-3659(98)00116-3.
    Open DOISearch in Google Scholar
  13. K. Zhang and X. Y. Wu, Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides,(2004) 5281-5291.
    Open DOISearch in Google Scholar
  14. Z. Y. Shen, M. Guang-Hui, D. Toshiaki, M. Yasuyuki and Z. G. Su, Preparation and characterization of thermo-responsive albumin nanospheres,(2008) 133-142; DOI: 10.1016/j.ijpharm.2007.06.004.
    Open DOISearch in Google Scholar
  15. S. S. Feng and G. Huang, Effects of emulsifiers on the controlled release of paclitaxel from nanoparticles of biodegradable polymers,(2001) 53-69; DOI: 10.1016/S0168-3659(00)00364-3.
    Open DOISearch in Google Scholar
  16. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers,(1983) 25-35. DOI: 10.1016/0378-5173(83)90064-9.
    Open DOISearch in Google Scholar
  17. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices,(1987) 37-42; DOI: 10.1016/0168-3659(87)90035-6.
    Open DOISearch in Google Scholar
  18. A. K. Philip and K. Pathak, Osmotic flow through assymetric membrane: A means for controlled delivery of drugs with varying solubility,(2006) E1-E11.
    Open DOISearch in Google Scholar
  19. D. N. Kapoor, F. V. Manvi, R. C. Doijad and S. Dhawan, Prednisolone loaded albumin nanospheres: in-vitro and in-vivo evaluation studies,(2008) 111-124.
    Search in Google Scholar
  20. K. Santhi, S. A. Dhanaraj, A. Ponnusankar and B. Suresh, Study on formulation and targeting efficiency of Amphotericin-B nanoparticles,(2000) 421-423.
    Search in Google Scholar
  21. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. V. Briesen and D. Schubert, Optimization of the preparation process for human serum albumin (HSA) nanoparticles,(2003) 169-180; DOI: 10.1016/S0378-5173(03)00134-0.
    Open DOISearch in Google Scholar
  22. W. Lin, A. G. A. Coombes, M. C. Davies, S. S. Davis and L. Illum, Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method,(1993) 237-243; DOI: 10.3109/10611869308996081.
    Open DOISearch in Google Scholar
  23. C. Narendra, M. S. Srinath and A. Moin, The study on the effect of formulation variables on in vitro floating time and the release properties of a floating drug delivery system by a statistical optimization technique,(2008) 17-26.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-011-0012-8 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian
Page range: 141 - 156
Published on: Jun 17, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
paclitaxel,
bovine serum albumin,
nanoparticles,
desolvation,
brain targeting,
factorial design
Related subjects:
Pharmacy,
Pharmacy, other

© 2011 Amit Bansal, Deepak Kapoor, Rishi Kapil, Neha Chhabra, Sanju Dhawan, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 61 (2011): Issue 2 (June 2011)
Previous article
Next article